In prostate cancer, apolipoprotein E (APOE) in the TME binds to TREM2 on macrophages and promotes androgen receptor (AR) expression, which further upregulates the transcription of immune mediators such as IL-10, TGF-β1, IL-23A, and CCL2. This evidence concerns the gene IL23A and prostate carcinoma.